. 2012 Sep 3;28(18):i589–i595. doi: 10.1093/bioinformatics/bts373

Table 2.

Sustained virologic response

	no risk	at risk
geno2pheno-C_Sanger	47%	42%
geno2pheno-C_Sanger⁺	46%	36%
geno2pheno-C_NGS–Sanger	47%	33%
geno2pheno-C_{NGS–Sanger⁺}	47%	31%
geno2pheno-C_NGS	48%	22%
Swenson et al.^a	(49%)	(26%)

Performance of the different methods regarding sustained virologic response defined as having a pVL lower than 50 copies/ml at week 48: The first number is the percentage of patients with a sustained virologic response that had been classified as no risk of X4 emergence and the second number gives this percentage for the patients classified as at risk of X4 emergence.

^aIn contrast to the other approaches, parts of the test data were utilized to optimize model parameters.